Zobrazeno 1 - 10
of 14
pro vyhledávání: ''
Publikováno v:
BMC Cardiovascular Disorders
Everolimus -eluting stent (EES) is common used in patients undergoing percutaneous coronary interventions (PCI). Our purpose is to evaluate long-term clinical outcomes of everolimus -eluting stent (EES) versus paclitaxel-eluting stent (PES) in patien
Autor:
Bjarne Madsen Hardig, David Sparv, Tobias Persson, Matthias Götberg, David Erlinge, Jan Harnek
Publikováno v:
BMC Cardiovascular Disorders
Effects of increased adenosine dose in the assessment of fractional flow reserve (FFR) were studied in relation to FFR results, hemodynamic effects and patient discomfort. FFR require maximal hyperemia mediated by adenosine. Standard dose is 140 μg/
Autor:
Wenjun Dai, Ailan Chen, Minsheng Chen, Xinchun Li, Caiwen Ou, Xinyu Chen, Wanglin Li, Qi Dong, Yuechun Shen
Publikováno v:
BMC Cardiovascular Disorders
Background Metabolism remodeling has been recognized as an early event following cardiac pressure overload. However, its temporal association with ventricular hypertrophy has not been confirmed. Moreover, whether trimetazidine could favorably affect
Publikováno v:
BMC Cardiovascular Disorders
Essential hypertension has been extensively reported to cause endothelial dysfunction. The aim of this study was to evaluate the effects of barnidipine or lercanidipine, in addition to losartan, on some parameters indicative of endothelial damage and
Publikováno v:
BMC Cardiovascular Disorders
Background Intensivists and cardiothoracic surgeons are commonly worried about surgical site infections (SSIs) due to increasing length of stay (LOS), costs and mortality. The antimicrobial prophylaxis is one of the most important tools in the preven
Autor:
Patricia Viviane Gaya, André Pacheco Silva, Alexandre C. Pereira, Tania Ogawa Abe, Gabriela Gouveia Pinheiro, Jaqueline Scholz, Paulo Caleb Junior Lima Santos
Publikováno v:
BMC Cardiovascular Disorders
Background Smoking is the most important reversible cardiovascular risk factor. It is well established that quitting smoking reduces coronary events. However, on several occasions, the cardiovascular safety of smoking cessation drugs has been questio
Autor:
Amir F Ayyobi, Hong Qian, Martha Mackay, Blair J. O'Neill, Nadia A. Khan, Shahzad Karim, Hude Quan, Danijela Gasevic, Gerald Simkus
Publikováno v:
BMC Cardiovascular Disorders
Background Little is known on whether there are ethnic differences in outcomes following percutaneous coronary intervention (PCI) and coronary artery bypass grafting surgery (CABG) after acute myocardial infarction (AMI). We compared 30-day and long-
Publikováno v:
BMC Cardiovascular Disorders
Background Accumulating evidence suggests that myeloperoxidase (MPO) is involved in atrial remodeling of atrial fibrillation (AF). Statins could reduce the MPO levels in patients with cardiovascular diseases. This study evaluated the effects of atorv
Autor:
Anthony Batte, Sarah Kiguli, Peter Lwabi, Sulaiman Lubega, Charles Karamagi, Violette Nabatte
Publikováno v:
BMC Cardiovascular Disorders
Background In Uganda, few children with congenital heart diseases (CHD) benefit from early corrective cardiac surgery. These children are at high risk of developing heart failure and electrolyte imbalances; factors which increase their risk of develo
Publikováno v:
BMC Cardiovascular Disorders
Background Few studies, if any, have examined cardiovascular outcomes in patients with diabetes and gout. Both diabetes and gout are risk factors for cardiovascular disease. The objective of this study was to examine the effect of allopurinol on the